We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.
See our privacy policy for more information on the use of your personal data.
Manage preferences for further information and to change your choices.
From: Development and validation of a Bayesian survival model for inclusion body myositis
Validation study
N
Study Duration (median)
Observed deaths
Predicted deaths
(base-case model)
Predicted deaths (saturated model)
Cox et al. [5] (overall)
64
12
72% [61%; 83%]
61% [57%; 66%]
76% [64%; 85%]
Benveniste et al. [4]
136
2.5
18% [12%; 25%]
14% [11%; 17%]
35% [27%; 43%]
